Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Long-Term Investments: 2022-2025

Historic Long-Term Investments for Harmony Biosciences Holdings (HRMY) over the last 4 years, with Sep 2025 value amounting to $105.8 million.

  • Harmony Biosciences Holdings' Long-Term Investments rose 12.32% to $105.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $105.8 million, marking a year-over-year increase of 12.32%. This contributed to the annual value of $108.9 million for FY2024, which is 50.86% up from last year.
  • According to the latest figures from Q3 2025, Harmony Biosciences Holdings' Long-Term Investments is $105.8 million, which was down 1.10% from $107.0 million recorded in Q2 2025.
  • Over the past 5 years, Harmony Biosciences Holdings' Long-Term Investments peaked at $108.9 million during Q4 2024, and registered a low of $4.7 million during Q2 2022.
  • Its 3-year average for Long-Term Investments is $85.0 million, with a median of $87.2 million in 2024.
  • Data for Harmony Biosciences Holdings' Long-Term Investments shows a peak YoY spiked of 1,135.54% (in 2023) over the last 5 years.
  • Quarterly analysis of 4 years shows Harmony Biosciences Holdings' Long-Term Investments stood at $22.6 million in 2022, then surged by 219.78% to $72.2 million in 2023, then spiked by 50.86% to $108.9 million in 2024, then increased by 12.32% to $105.8 million in 2025.
  • Its Long-Term Investments was $105.8 million in Q3 2025, compared to $107.0 million in Q2 2025 and $103.2 million in Q1 2025.